Moges Solomon, Belete Tilahun, Mekonen Tesfa, Menberu Melak
College of Health Sciences, Department of Psychiatry, Woldia University, Woldia, Ethiopia.
College of Medicine and Health Sciences, Department of Psychiatry, Bahir Dar University, Bahir Dar, Ethiopia.
Int J Ment Health Syst. 2021 May 6;15(1):42. doi: 10.1186/s13033-021-00464-0.
Relapse in psychiatric disorders is highly distressing that posed a huge burden to the patients, family, and society. It interrupts the process of recovery and may increase the risk of resistance to treatment. Relapse detection and taking preventive measures against its possible factors are crucial for a better prognosis.
To assess lifetime relapse and its associated factors among people with schizophrenia spectrum disorders who are on follow-up at Comprehensive Specialized Hospitals in Amhara region, Ethiopia.
An institution-based cross-sectional study was conducted from July 13-August 13, at Comprehensive Specialized Hospitals in Amhara region, Ethiopia, 2020. Data were collected from 415 randomly selected participants using an interviewer administered questionnaire. Relapse was determined using participants' medical records and a semi-structured questionnaire. Data were analyzed using Statistical Package for Social Sciences (SPSS) version 25. Logistic regression analysis was done to identify the explanatory variables of relapse. Variables with P-value < 0.05 were considered significantly associated with relapse.
The magnitude of lifetime relapse was 57.4% (95% CI = 53-62%). Relapse was significantly associated with comorbidity of another mental illness (AOR = 1.84, 95% CI = 1.06, 3.18), non-adherence to medication (AOR = 2.23, 95% CI = 1.22, 4.07), shorter duration on treatment (AOR = 1.71, 95% CI = 1.05, 2.81), and experiencing stressful life events (AOR = 2.42, CI = 1.2, 4.66).
In the current study, more than half of the participants had lifetime relapses. Comorbid mental illnesses, non-adherence, duration of treatment ≤ 5 years, and experiencing stressful life events were factors associated with relapse. This requires each stakeholder to give concern and work collaboratively on the respective factors that lead to relapse.
精神疾病的复发令人极为痛苦,给患者、家庭和社会带来了巨大负担。它会中断康复进程,并可能增加治疗抵抗的风险。复发检测以及针对其可能因素采取预防措施对于改善预后至关重要。
评估在埃塞俄比亚阿姆哈拉地区综合专科医院接受随访的精神分裂症谱系障碍患者的终生复发情况及其相关因素。
2020年7月13日至8月13日在埃塞俄比亚阿姆哈拉地区的综合专科医院开展了一项基于机构的横断面研究。使用访谈员管理的问卷从415名随机选择的参与者中收集数据。通过参与者的病历和半结构化问卷确定复发情况。使用社会科学统计软件包(SPSS)25版进行数据分析。进行逻辑回归分析以确定复发的解释变量。P值<0.05的变量被认为与复发显著相关。
终生复发率为57.4%(95%CI=53-62%)。复发与另一种精神疾病的共病(比值比[AOR]=1.84,95%CI=1.06,3.18)、不遵医嘱服药(AOR=2.23,95%CI=1.22,4.07)、治疗时间较短(AOR=1.71,95%CI=1.05,2.81)以及经历应激性生活事件(AOR=2.42,CI=1.2,4.66)显著相关。
在本研究中,超过一半的参与者有终生复发情况。共病精神疾病、不遵医嘱、治疗时间≤5年以及经历应激性生活事件是与复发相关的因素。这要求每个利益相关者关注并共同应对导致复发的各自因素。